CAR-T cell therapy

Facts for Prelims (FFP)   Source: The Print   Context: India’s Drug Controller General (DCGI) has granted market authorization for CAR-T (Chimeric Antigen Receptor-T) cell therapy developed by ImmunoACT, a spin-off company from IIT-Bombay. This ground-breaking treatment, known as NexCAR19, is now approved for use in cases of relapsed-refractory B-cell lymphoma and leukaemia. The therapy’s …

[Mission 2023] INSIGHTS DAILY CURRENT AFFAIRS + PIB SUMMARY 10 February 2023

InstaLinks :  help you think beyond the issue but relevant to the issue from UPSC prelims and Mains exam point of view. These linkages provided in this ‘hint’ format help you frame possible questions ina your mind that might arise(or an examiner might imagine) from each current event. InstaLinks also connect every issue to their …